177 related articles for article (PubMed ID: 28576663)
41. A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images.
Venkataraman R; Belardinelli L; Blackburn B; Heo J; Iskandrian AE
JACC Cardiovasc Imaging; 2009 Nov; 2(11):1301-9. PubMed ID: 19909934
[TBL] [Abstract][Full Text] [Related]
42. Glucose-Lowering Medications and Angina Burden in Patients with Stable Coronary Disease: results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Trial.
Arnold SV; McGuire DK; Spertus JA; Tang F; Yue P; Inzucchi SE; Belardinelli L; Chaitman BR; Kosiborod M
Am Heart J; 2015 Oct; 170(4):753-759.e2. PubMed ID: 26386799
[TBL] [Abstract][Full Text] [Related]
43. Quantitative Flow Ratio-Derived Index of Microcirculatory Resistance as a Novel Tool to Identify Microcirculatory Function in Patients with Ischemia and No Obstructive Coronary Artery Disease.
Gao B; Wu G; Xie J; Ruan J; Xu P; Qian Y; Gu J; Li W; Jin X; Tong G; Huang J
Cardiology; 2024; 149(1):14-22. PubMed ID: 37839404
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of Ranolazine for Treatment of Coronary Microvascular Dysfunction-A Systematic Review and Meta-analysis of Randomized Trials.
Kofler T; Hess S; Moccetti F; Pepine CJ; Attinger A; Wolfrum M; Toggweiler S; Kobza R; Cuculi F; Bossard M
CJC Open; 2021 Jan; 3(1):101-108. PubMed ID: 33458636
[TBL] [Abstract][Full Text] [Related]
45. Ranolazine versus placebo in patients with ischemic cardiomyopathy and persistent chest pain or dyspnea despite optimal medical and revascularization therapy: randomized, double-blind crossover pilot study.
Shammas NW; Shammas GA; Keyes K; Duske S; Kelly R; Jerin M
Ther Clin Risk Manag; 2015; 11():469-74. PubMed ID: 25848292
[TBL] [Abstract][Full Text] [Related]
46. Angina relates to coronary flow in women with ischemia and no obstructive coronary artery disease.
Suppogu N; Wei J; Quesada O; Shufelt C; Cook-Wiens G; Samuels B; Petersen JW; Anderson RD; Handberg EM; Pepine CJ; Bairey Merz CN
Int J Cardiol; 2021 Jun; 333():35-39. PubMed ID: 33662486
[TBL] [Abstract][Full Text] [Related]
47. Impact of Targeted Therapies for Coronary Microvascular Dysfunction as Assessed by the Index of Microcirculatory Resistance.
Xu J; Lo S; Juergens CP; Leung DY
J Cardiovasc Transl Res; 2021 Apr; 14(2):327-337. PubMed ID: 32710373
[TBL] [Abstract][Full Text] [Related]
48. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
Melloni C; Newby LK
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
[TBL] [Abstract][Full Text] [Related]
49. New Anti-Anginal Drugs: Ranolazine.
Cavallino C; Facchini M; Veia A; Bacchni S; Rosso R; Rognoni A; Rametta F; Lupi A; Bongo AS
Cardiovasc Hematol Agents Med Chem; 2015; 13(1):14-20. PubMed ID: 25544118
[TBL] [Abstract][Full Text] [Related]
50. Ranolazine reduces patient-reported angina severity and frequency and improves quality of life in selected patients with chronic angina.
Muhlestein JB; Grehan S
Drugs R D; 2013 Sep; 13(3):207-13. PubMed ID: 23990357
[TBL] [Abstract][Full Text] [Related]
51. Use of Ranolazine for the Treatment of Coronary Microvascular Dysfunction.
Sharp RP; Patatanian E; Sirajuddin R
Am J Cardiovasc Drugs; 2021 Sep; 21(5):513-521. PubMed ID: 33438139
[TBL] [Abstract][Full Text] [Related]
52. Coronary microcirculatory resistance is independent of epicardial stenosis.
Yong AS; Ho M; Shah MG; Ng MK; Fearon WF
Circ Cardiovasc Interv; 2012 Feb; 5(1):103-8, S1-2. PubMed ID: 22298800
[TBL] [Abstract][Full Text] [Related]
53. Non-haemodynamic anti-anginal agents in the management of patients with stable coronary artery disease and diabetes: A review of the evidence.
Ambrosio G; Tamargo J; Grant PJ
Diab Vasc Dis Res; 2016 Mar; 13(2):98-112. PubMed ID: 26873904
[TBL] [Abstract][Full Text] [Related]
54. Open-label trial of ranolazine for the treatment of myotonia congenita.
Arnold WD; Kline D; Sanderson A; Hawash AA; Bartlett A; Novak KR; Rich MM; Kissel JT
Neurology; 2017 Aug; 89(7):710-713. PubMed ID: 28710329
[TBL] [Abstract][Full Text] [Related]
55. Ranolazine for Treatment of Angina or Dyspnea in Hypertrophic Cardiomyopathy Patients (RHYME).
Gentry JL; Mentz RJ; Hurdle M; Wang A
J Am Coll Cardiol; 2016 Oct; 68(16):1815-1817. PubMed ID: 27737749
[No Abstract] [Full Text] [Related]
56. Ranolazine for improving coronary microvascular function in patients with nonobstructive coronary artery disease: a systematic review and meta-analysis with a trial sequential analysis of randomized controlled trials.
Ling H; Fu S; Xu M; Wang B; Li B; Li Y; Liu X; Zhang X; Wang Q; Li A; Liu M
Quant Imaging Med Surg; 2024 Feb; 14(2):1451-1465. PubMed ID: 38415135
[TBL] [Abstract][Full Text] [Related]
57. Coronary Sinus Narrowing Improves Coronary Microcirculation Function in Patients With Refractory Angina: A Multicenter Prospective INROAD Study.
Tebaldi M; Campo G; Ugo F; Guarracini S; Marrone A; Clò S; Abdirashid M; Di Mauro M; Rametta F; Di Marco M; Cocco M; Marchini F; Penzo C; Erriquez A; Banai S; Biscaglia S
Circ Cardiovasc Interv; 2024 Jan; 17(1):e013481. PubMed ID: 38227697
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial.
Wilson SR; Scirica BM; Braunwald E; Murphy SA; Karwatowska-Prokopczuk E; Buros JL; Chaitman BR; Morrow DA
J Am Coll Cardiol; 2009 Apr; 53(17):1510-6. PubMed ID: 19389561
[TBL] [Abstract][Full Text] [Related]
59. [Triple antianginal combinations in the treatment of elderly and senile patients with stable angina].
Kanorskii SG; Smolenskaya NV
Ter Arkh; 2016; 88(12):33-40. PubMed ID: 28139557
[TBL] [Abstract][Full Text] [Related]
60. Cost-effectiveness of ranolazine added to standard-of-care treatment in patients with chronic stable angina pectoris.
Kohn CG; Parker MW; Limone BL; Coleman CI
Am J Cardiol; 2014 Apr; 113(8):1306-11. PubMed ID: 24560062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
